Regenity Biosciences Overview

Medical ProductsCompany

Is Regenity Biosciences PE-backed?

Yes. Regenity Biosciences is owned by private equity investors Audax Private Debt, Golub Capital, Linden Capital Partners and Northwestern Mutual Capital.

Was Regenity Biosciences formerly PE-backed?

Yes. Regenity Biosciences was formerly owned by 1 private investor.

Where is Regenity Biosciences headquartered?

Regenity Biosciences is headquartered in Paramus, New Jersey.

What sector is Regenity Biosciences in?

Regenity Biosciences is a medical products company.

When was Regenity Biosciences founded?

Regenity Biosciences was founded in 1997.

Regenity Biosciences

Regenity Biosciences

115 W., Century Rd., Suite 380,
Paramus, New Jersey 07652
United States,
(201) 405-1477
www.regenity.com

Regenity Biosciences is a developer and manufacturer of collagen-based medical products used for tissue and bone repair and regeneration. Regenity Biosciences develops proprietary products that are sold to OEM customers on either a contract or private label basis across orthopedic, sports medicine, dental, and neurosurgery end markets. Regenity Biosciences also offers partnership opportunities including distribution, contract product development, and contract manufacturing services. Regenity Biosciences was founded in 1997 and is based in Paramus, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # 1 - 1 - - - 2
Sell (0.0/yr) # - - - - - - 0
  2

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.